Skip to main content
Clinical Trials/NCT03218124
NCT03218124UnknownNot Applicable

Optimal Effect Site Remifentanil Concentration for Smooth Extubation After Thyroid Surgery

University of Cagliari1 site in 1 country30 target enrollmentStarted: October 1, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
30
Locations
1
Primary Endpoint
Cough

Study Overview

Brief Summary

The study is aimed at determining the remifentanil effect site concentration suppressing the cough at extubation after surgical thyroidectomy, performed under remifentanil/desflurane based general anesthesia, expressed as median and 95th percentile effective dose.

Possible hemodynamic instability, respiratory depression or prolongation of awakening time are also sought.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Masking Description

Patient under general anesthesia unaware of the effect site concentration of remifentanil before extubation

Eligibility Criteria

Ages
18 Years to 67 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •18<age<67
  • •6 hrs fasting
  • •American society of anesthesiology (ASA) Physical Status I o II
  • •Informed consent

Exclusion Criteria

  • •Absence of inclusion criteria
  • •Use of cough suppressors, angiotensin converting enzyme-inhibitors, sedatives 4 weeks before surgery
  • •Arhythmia, pacemaker or unstable cardiovascular disease
  • •Hepatic or renal failure
  • •Anticipated difficulty in airways management
  • •Chronic obstructive pulmonary disease (COPD), Asthma, increased risk for inhalation, airway infection in the previous 4 weeks;
  • •Obesity (BMI >35)
  • •Pregnancy
  • •Hypersensitivity to drugs administered for the study

Arms & Interventions

remifentanil

Experimental

After skin suture, a predetermined Effect site remifentanil concentration will be achieved. Starting from 1.5 ng/ml in the first patient and increased or decreased by 0.2 ng/ml intervals based on the previous patient response: up if cough present, down otherwise ("Dixon's up and down" method).

Intervention: Remifentanil Effect site concentration (Other)

Outcomes

Primary Outcomes

Cough

Time Frame: 15 minutes after surgery

Any episode of sudden and violent abdominal contraction interrupting normal quite spontaneous or assisted ventilation would be accounted as "cough" and defines non-smooth extubation

Secondary Outcomes

  • Hemodynamics 1(15 minutes after surgery)
  • Hemodynamics 2(15 minutes after surgery)
  • Respiratory outcome 1(15 minutes after surgery)
  • Respiratory outcome 2(15 minutes after surgery)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Prof. Gabriele Finco

Professor of Anesthesiology and Intensive Care

University of Cagliari

Study Sites (1)

Loading locations...

Similar Trials